There is no clear association between tumor-infiltrating lymphocytes (CD3+, CD4+, or CD8+ T cell infiltrates) and overall survival in patients with glioblastoma/glioma (Table 2) (58, 60, 203, 205, 208–210, 218–230). This evidence concerns the gene CD4 and glioma.